CDC Updates Practice Recommendations for Contraceptives

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 9, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 9, 2024 -- In two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.

Kathryn M. Curtis, Ph.D., from the CDC in Atlanta, and colleagues updated recommendations for health care providers relating to initiation and use of specific contraceptive methods after a review of the evidence. The updates include recommendations for provision of medications for intrauterine device placement; recommendations for bleeding irregularities during use of implants; recommendations for use of testosterone and risk for pregnancy; and recommendations for injectable contraception self-administration.

Antoinette T. Nguyen, M.D., also from the CDC, and colleagues updated recommendations for the use of specific contraceptive methods by persons with certain characteristics or medical conditions. Updates include the addition of recommendations for individuals with chronic kidney disease; revisions to the recommendations for persons with specific characteristics or conditions, including breastfeeding, postpartum, obesity, surgery, high risk for HIV infection, cirrhosis, liver tumor, sickle cell disease, and solid organ transplantation; and inclusion of new contraceptive methods, such as new combined oral contraceptives, contraceptive patches, vaginal rings, progestin-only pills, levonorgestrel intrauterine devices, and vaginal pH modulators.

"Voluntary informed choice of contraceptive methods is an essential guiding principle of these recommendations, and person-centered contraceptive counseling can help to ensure a person's contraceptive needs are met successfully," Nguyen and colleagues write.

U.S. Selected Practice Recommendations for Contraceptive Use, 2024

U.S. Medical Eligibility Criteria for Contraceptive Use, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-10 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords